Unions call for full return to hybrid working in Parliament

The FDA, jointly with Prospect, has written to the Speaker of the House of Commons calling for a return to full hybrid arrangements in the House of Commons.
With London now in Tier 2 restrictions, and MPs travelling from all over the country, including areas in Tier 3, the letter from the FDA and Prospect argues: “In order to prevent the very real risk of a worsening crisis forcing Parliament to close, it is surely sensible that Parliament returns to remote working to protect staff and MPs and ensure that the important work of Parliament can continue in its vital work of holding the Government to account”.
FDA Assistant General Secretary Amy Leversidge said: “It is absolutely vital that MPs are able to effectively hold the government to account in the coming months. However, the House authorities also have a duty of care to all those who work on the parliamentary estate.
“Therefore, it is absolutely crucial that the government changes course and gives its support to a return to hybrid working. MPs proved earlier this year that it was possible to participate in the proceedings of the House remotely, ensuring continued scrutiny of government decisions, whilst protecting staff”.
Leversidge also pointed out that, with infections continuing to rise and more areas of the country facing tightening restrictions, the government needed “to put the health and safety of all those who work in Parliament first”.
Related News
-
FDA Ofsted report 2025: The people behind inspections
After a barrage of media criticism and calls for abolition, it’s been a difficult period for His Majesty’s Inspectors (HMI). Tommy Newell outlines the findings of the FDA’s recent report, revealing the reality of parents’ and educators’ views of Ofsted, and what HMIs need for an inspection system fit for the future.
-
-
Organising: a community of practice
FDA Head of Organising and Learning Deri Bevan on the rise in HEO, SEO and graduate scheme members who are increasingly active within the FDA. Plus, trends and feedback from this year’s FDA Learn calendar.